Listeria infections associated with infliximab: case reports

@article{Kesteman2007ListeriaIA,
  title={Listeria infections associated with infliximab: case reports},
  author={Thomas Kesteman and J Cyr Yombi and Jacques Gigi and Patrick Durez},
  journal={Clinical Rheumatology},
  year={2007},
  volume={26},
  pages={2173-2175}
}
Infliximab is a human-murine chimeric monoclonal antibody directed against tumor necrosis factor α (TNFα). Infliximab and other TNF blockers are used to treat inflammatory diseases such as rheumatoid arthritis (RA). TNF blockers are suspected to play a key role in some infections. We report here two cases of Listeria monocytogenes sepsis associated with infliximab treatment for RA. The first patient developed a terminal ileitis and a bacteraemia after three doses of infliximab; the second RA… CONTINUE READING
16 Citations
14 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-10 of 16 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 14 references

Fouryears effects of infliximab utilisation in a large multicentric Belgian cohort of patients presenting refractory rheumatoid arthritis

  • P Durez, B Vander Cruyssen, R Westhovens
  • Ann Rheum Dis
  • 2006
1 Excerpt

Similar Papers

Loading similar papers…